ARTICLE | Clinical News
Scotia Holdings Group regulatory update
January 26, 1998 8:00 AM UTC
SOH's Scotia Pharmaceuticals Ltd. subsidiary received U.K. approval to market once per day oral emulsion formulations of Epogam to treat atopic eczema and Efamast to treat breast pain, and a topical c...